These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 237741)
41. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice. Nguyen N; Fakra E; Pradel V; Jouve E; Alquier C; Le Guern ME; Micallef J; Blin O Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522 [TBL] [Abstract][Full Text] [Related]
42. A study in the management of anxiety with lorazepam. Ellison RJ; Cancellaro LA J Clin Pharmacol; 1978 Apr; 18(4):210-9. PubMed ID: 24646 [TBL] [Abstract][Full Text] [Related]
43. Lormetazepam - a benzodiazepine derivative without hangover effect? A double-blind study with chronic insomniacs in a general practice setting. Heidrich H; Ott H; Beach RC Int J Clin Pharmacol Ther Toxicol; 1981 Jan; 19(1):11-7. PubMed ID: 6110634 [TBL] [Abstract][Full Text] [Related]
48. [Lorazepam (Temesta) versus bromazepam (Lexotanil). A controlled cross-study]. Modestin J; Hodel J MMW Munch Med Wochenschr; 1976 Oct; 118(41):1335-6. PubMed ID: 11410 [No Abstract] [Full Text] [Related]
49. Lorazepam, a new benzodiazepine derivative, in the treatment of anxiety: a double-blind clinical evaluation. McCurdy L Am J Psychiatry; 1979 Feb; 136(2):187-90. PubMed ID: 32776 [TBL] [Abstract][Full Text] [Related]
50. Alprazolam in the treatment of neurotic anxiety. Kerry RJ; McDermott CM Pharmatherapeutica; 1983; 3(7):451-5. PubMed ID: 6142462 [TBL] [Abstract][Full Text] [Related]
51. [Alprazolam versus lorazepam in the treatment of anxiety: controlled clinical study]. Bernardi F; Fossi L; Faravelli C; Corsini GU; Varricchio MC Riv Patol Nerv Ment; 1984; 105(1):1-13. PubMed ID: 6571441 [TBL] [Abstract][Full Text] [Related]
53. Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder. Cohn JB; Wilcox CS Pharmacotherapy; 1984; 4(2):93-8. PubMed ID: 6144090 [TBL] [Abstract][Full Text] [Related]
54. How to ensure clinical trial sensitivity in psychotropic drug development: a case study. Videla S; Sust M; Fresquet A; Villoria J Clin Ther; 2005 Feb; 27(2):252-4. PubMed ID: 15811489 [No Abstract] [Full Text] [Related]
55. A comparison of high- and low-dose lorazepam with amylobarbitone in patients with anxiety states. Schapira K; McClelland HA; Newell DJ Am J Psychiatry; 1977 Jan; 134(1):25-8. PubMed ID: 12665 [TBL] [Abstract][Full Text] [Related]
56. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam. Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Morales-Valdéz M; García-Valencia CE; Tortoriello J Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493 [TBL] [Abstract][Full Text] [Related]
57. Lorazepam and diazepam in the treatment of benign paroxysmal vertigo. McClure JA; Willett JM J Otolaryngol; 1980 Dec; 9(6):472-7. PubMed ID: 6110782 [TBL] [Abstract][Full Text] [Related]
58. Clinical use of lorazepam in postoperative intensive care. Camu F Acta Anaesthesiol Belg; 1978; 29(2):191-200. PubMed ID: 32731 [No Abstract] [Full Text] [Related]
59. Placebo controlled study with tofisopam in anxious neurosis. Sladká R; Dostálová J; Haskovcová V; Jarosová M; Slánská J; Faltus F; Filip V Act Nerv Super (Praha); 1978 Dec; 20(4):245-6. PubMed ID: 32724 [No Abstract] [Full Text] [Related]